Abata Therapeutics

Abata Therapeutics

Biotechnology, 245 1st St, Cambridge, Massachusetts, 02142, United States, 11-50 Employees

abatatx.com

  • facebook
  • twitter
  • LinkedIn

Who is ABATA THERAPEUTICS

We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis a sta...

Read More

map
  • 245 1st St, Cambridge, Massachusetts, 02142, United States Headquarters: 245 1st St, Cambridge, Massachusetts, 02142, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ABATA THERAPEUTICS

Abata Therapeutics Org Chart and Mapping

Employees

Eugene Antipov

Sr. Director, Process Development

Taylor Bolduc

Administrative Assistant

Krish Parekh

Technical Operations Co-Op

Alec Silverman

Senior Research Associate

Jefte Drijvers

Director, Program Leadership

Stephen Sofen

Chief Technical Officer

Geetha Mylvaganam

Senior Director, Head of Research

Christina Strange

Senior Director, Analytical Development

Cristin Berkey

Senior Director of Intellectual Property and Contracts

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Abata Therapeutics

Answer: Abata Therapeutics's headquarters are located at 245 1st St, Cambridge, Massachusetts, 02142, United States

Answer: Abata Therapeutics's official website is https://abatatx.com

Answer: Abata Therapeutics's revenue is $1 Million to $5 Million

Answer: Abata Therapeutics's SIC: 2836

Answer: Abata Therapeutics's NAICS: 541714

Answer: Abata Therapeutics has 11-50 employees

Answer: Abata Therapeutics is in Biotechnology

Answer: Abata Therapeutics contact info: Phone number: Website: https://abatatx.com

Answer: We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis a state of harmony and promote repair in the affected tissues. In addition to our lead program in progressive MS, Abata has early programs in Type 1 Diabetes (T1D) and inclusion body myositis (IBM). We bring together industry experts and deeply engaged pioneers in Treg biology, T cell receptor and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers. We are bold in our mission and purpose and aim for nothing less than a transformative impact on peoples lives.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access